• Noriaki Kamada, Kei Yoneyama, Yaei Togawa, Keisuke Suehiro, Hiroshi Shinkai, Masaya Yokota, Kenichi Matsuda, Shigeto Oda, Hiroyuki Hirasawa, and Hiroyuki Matsue.
• Department of Dermatology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan. ozmail@faculty.chiba-u.jp
• J. Dermatol. 2010 Jun 1;37(6):534-6.

AbstractToxic epidermal necrolysis is a life-threatening skin disorder, and its mortality rate is estimated to be approximately 20-30%. It is characterized that more than 30% of the skin surface is eroded, however, skin lesions are usually re-epithelialized within 2-3 weeks. Previously, we reported a fatal case of toxic epidermal necrolysis with hyperbilirubinemia, and more than 60% of body surface areas had been eroded for 9 weeks. For the reason of delayed re-epithelialization, we hypothesized that hyperbilirubinemia was the culprit because bilirubin damaged cultured keratinocytes in vitro. In this case, we had an opportunity to treat another case of toxic epidermal necrolysis with severe hyperbilirubinemia. In order to reduce serum bilirubin levels, we performed bilirubin adsorption therapies, and skin lesions were successfully re-epithelialized within 4 weeks. Though further studies are required, we considered that bilirubin adsorption therapies are worth trying for toxic epidermal necrolysis with hyperbilirubinemia, especially for the cases suffering from delayed re-epithelialization.

16 keywords...

hide…